IGC
IGC
AMEX · Pharmaceuticals

Igc Pharma Inc

$0.29
+0.02 (+6.98%)
As of Sep 20, 10:59 PM ET ·
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target +5,387.7% upside
Low Target $13.90
Average Target $15.64
High Target $22.29
Current Price $0.29
Current
$0.29
Target
$15.64
$13.90 $15.64 avg $22.29
Scenario Analysis
Bear Case
$13.90
4,777.2%
Low target
Base Case
$15.64
+5,387.7%
Avg target
Bull Case
$22.29
+7,721.1%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$0.45
-36.8% from high
52-Week Low
$0.24
+21.3% from low
Target vs 52W High
$15.64
+3,369.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%